(2541466), M. Q., (15010), P. M., (104852), Y. Z., (95017), H. J., (22686257), L. G., (8495742), G. L., . . . (8665254), J. G. (2025). Table 1_Immune checkpoint inhibitor therapy in advanced cancer: Clinical association of irAEs type, inflammatory markers and efficacy.docx.
Chicago-referens (17:e uppl.)(2541466), Mengying Qian, Ping Ma (15010), Yu Zhao (104852), Hao Jiang (95017), LiYang Gao (22686257), Gaoyang Lin (8495742), Difan Duan (22686260), och Jinmin Guo (8665254). Table 1_Immune Checkpoint Inhibitor Therapy in Advanced Cancer: Clinical Association of IrAEs Type, Inflammatory Markers and Efficacy.docx. 2025.
MLA-referens (9:e uppl.)(2541466), Mengying Qian, et al. Table 1_Immune Checkpoint Inhibitor Therapy in Advanced Cancer: Clinical Association of IrAEs Type, Inflammatory Markers and Efficacy.docx. 2025.